Search results for "World health"

showing 10 items of 184 documents

Contingency Plan for the Intensive Care Services for the COVID-19 pandemic

2020

In January 2020, the Chinese authorities identified a new virus of the Coronaviridae family as the cause of several cases of pneumonia of unknown aetiology. The outbreak was initially confined to Wuhan City, but then spread outside Chinese borders. On 31 January 2020, the first case was declared in Spain. On 11 March 2020, The World Health Organization (WHO) declared the coronavirus outbreak a pandemic. On 16 March 2020, there were 139 countries affected. In this situation, the Scientific Societies SEMICYUC and SEEIUC, have decided to draw up this Contingency Plan to guide the response of the Intensive Care Services. The objectives of this plan are to estimate the magnitude of the problem a…

PandemiaContingency planPandemicCoronavirus disease 2019 (COVID-19)SARS-CoV-2Unknown aetiologyCOVID-19Outbreak030208 emergency & critical care medicinemedicine.diseaseArticleWorld healthCoronavirus03 medical and health sciences0302 clinical medicine030228 respiratory systemIntensive careMaterial resourcesPandemicmedicineMedical emergencyBusinessEnfermería Intensiva (English ed.)
researchProduct

Rapid malignant progression of an intraparenchymal choroid plexus papillomas

2018

Background: Choroid plexus tumors (CPTs) are rare neoplasms accounting for only 0.3-0.6% of all brain tumors in adults and 2-5% in children. The World Health Organization (WHO) classification describes three histological grades: grade I is choroid plexus papilloma (CPP), grade II is atypical papilloma, and grade III is the malignant form of carcinoma. In adults, CPTs rarely have a supratentorial localization. Case Description: Here we report a very rare case of an intraparenchymal parietal CPP with a rapid histological transition from grade I to grade III WHO in a 67-year-old man, in <7 months. Conclusion: Because of the rarity of these oncotypes, descriptions of each new case are useful…

Pathologymedicine.medical_specialtyChoroid plexus atypical papillomaWorld health03 medical and health sciences0302 clinical medicineCarcinomaMedicinechoroid plexus papillomasSettore MED/27 - Neurochirurgiabusiness.industrychoroid plexus carcinomaGeneral Neurosurgery: Case Reportmalignant progressionChoroid plexus carcinomamedicine.diseaseChoroid plexus papilloma030220 oncology & carcinogenesischoroid plexus papillomaPapillomaSurgeryChoroid plexusNeurology (clinical)Histological gradesMalignant progressionbusinessWorld Health Organization classification030217 neurology & neurosurgerySurgical Neurology International
researchProduct

Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report

2013

Diffuse large B-cell lymphoma (DLBCL) is the most frequent type of non-Hodgkin´s lymphoma found in oral and maxillofacial regions. A large number of cases may be biologically heterogeneous, which are commonly defined as DLBCL, not otherwise specified (NOS) by the World Health Organization (WHO-2008). The present case reports on an ulcer of raised and irregular edges, found on the border between the hard and soft palate, as the first and only manifestation of an extranodal non-Hodgkin lymphoma in an 85-year-old patient. Incisional biopsy was carried out, and the specimen revealed a proliferation of large lymphoid cells suggestive of diffuse large cell lymphoma. An immunohistochemical analysi…

Pathologymedicine.medical_specialtyIncisional biopsyPrognostic factorOral Medicine and PathologySoft palatebusiness.industryNot Otherwise SpecifiedOdontologíaCase Report:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludWorld healthLymphomamedicine.anatomical_structureimmune system diseaseshemic and lymphatic diseasesUNESCO::CIENCIAS MÉDICASmedicineImmunohistochemistrybusinessGeneral DentistryDiffuse large B-cell lymphomaJournal of Clinical and Experimental Dentistry
researchProduct

Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study…

2014

BACKGROUND: The fifth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100,000 livebirths) between 1990 and 2015. We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery.METHODS: We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to analyse a database of data for 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries between 1990 and 2013. We estimated the number of pregnancy-related deaths caused by HIV on the basi…

PediatricsTime FactorsNutrition and Diseasehiv-infectionimmunodeficiency virus-1 infectionperipartum cardiomyopathyPoison controlHIV InfectionsIMMUNODEFICIENCY VIRUS-1 INFECTIONSocioeconomic FactorGlobal Health0302 clinical medicinePERIPARTUM CARDIOMYOPATHYpregnancy-related mortalityRisk FactorsPregnancyVoeding en ZiekteCause of DeathGlobal healthHIV Infection030212 general & internal medicinePregnancy Complications Infectious10. No inequalityCause of death030219 obstetrics & reproductive medicinesouth-africaMedicine (all)1. No povertyWOMENPREGNANCY-RELATED MORTALITYhealth initiativesGeneral MedicineSOUTH-AFRICA3. Good healthMaternal MortalityWorld HealthCHILD SURVIVALFemaleMaternal deathwomenHumanmedicine.medical_specialtyTime FactorDEATHSchild survivalArticleadult mortality03 medical and health sciencesAge DistributionHEALTH INITIATIVESSDG 3 - Good Health and Well-beingHIV-INFECTIONADULT MORTALITYInjury preventionmedicineOrganizational ObjectivesOrganizational ObjectiveHumansVLAGPregnancyModels Statisticalbusiness.industryRisk Factormedicine.diseasedeathsStandardized mortality ratioSocioeconomic FactorsRelative riskPregnancy Complications InfectioubusinessDemography
researchProduct

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling…

2017

Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% reduction in liver-related deaths, a 90% reduction of new viral hepatitis infections, and 90% of patients with viral hepatitis infections being diagnosed by 2030. This study assessed the prevalence of HCV in the EU and the level of intervention required to achieve WHO targets for HCV elimination. Methods We populated country Markov models for the 28 EU countries through a literature search of PubMed and Embase between Jan 1, 2000, and March 31, 201…

Pediatricsddc:616.07medicine.disease_cause0302 clinical medicineCost of IllnessEpidemiologyPrevalenceEPIDEMIOLOGY030212 general & internal medicineSettore SECS-P/01 - Economia PoliticaCIRRHOSISmedia_commonddc:616Antiviral Agents/therapeutic useeducation.field_of_studyINJECT DRUGSGastroenterologyHCV INFECTIONvirus diseasesHepatitis CEmigration and ImmigrationDISEASE BURDENHepatitis CMarkov ChainsEmigration and Immigration/statistics & numerical data030211 gastroenterology & hepatologyViral hepatitisModelling ; Eradication ; European Union ; Hepatitis C ; prevalenceCOUNTRIESmedicine.medical_specialtyHepatitis C virusPopulationUNITED-STATESWorld Health OrganizationAntiviral Agents03 medical and health sciencesSDG 3 - Good Health and Well-beingPEOPLEInternal medicineIntervention (counseling)medicineJournal Articlemedia_common.cataloged_instanceHumansEuropean UnionViremiaEuropean unionDisease EradicationeducationHepatitis C/diagnosis/drug therapy/epidemiology/prevention & controlHepatologybusiness.industryViremia/diagnosis/drug therapy/epidemiology/prevention & controlHepatologymedicine.diseaseVirologyPREVENTIONdigestive system diseasesHuman medicineVIRAL-HEPATITISbusinessLancet Gastroenterology & Hepatology
researchProduct

Postmortem Imaging in Sudden Adult Death

2019

Several definitions of “sudden and unexpected death” exist. The World Health Organization definition is of natural death within 24 h from the onset of symptoms, but this is much too long for many clinicians and pathologists; some will only accept death within 1 h from the onset of illness. If the event was not witnessed, sudden death is defined as the interval between the time the subject was last seen and the time the body was found within 6 h.

Pediatricsmedicine.medical_specialtybusiness.industryNatural deathCardiac pathologyForensic radiologyMedicinebusinessUnexpected deathSudden deathWorld health
researchProduct

Body composition in children and adolescents residing in southern Europe: Prevalence of overweight and obesity according to different international r…

2019

The objective was to analyze body composition in children and adolescents of Southern Europe to identify prevalence of overweight and obesity. This investigation involved 512 girls and 488 boys between 7-to 19-years. Variables evaluated were Body Mass Index (BMI) and Fat Mass (FM; electrical bioimpedance). The references used to establish prevalence according to BMI were those of the World Health Organization (WHO) and the International Obesity Task Force (IOTF); in the case of FM, the Child Growth Foundation (CGF) reference was used. There were significant differences (p < 0.05) in the prevalence of overweight and obesity between the three classifications (32.3% according to IOTF, 37.3%…

PhysiologyConcordance030209 endocrinology & metabolismOverweightlcsh:PhysiologyWorld healthFat mass03 medical and health sciencesBMIWHO0302 clinical medicineBMI; CGF; IOTF; WHO; fat mass; nutritional status030225 pediatricsPhysiology (medical)IOTFmedicineCGFOriginal ResearchSettore M-EDF/01 - Metodi e Didattiche delle Attivita' Motorielcsh:QP1-981business.industryTask forcefat massmedicine.diseaseObesitynutritional statusfat mass BMI nutritional status WHO IOTF CGFmedicine.symptombusinessBody mass indexKappaDemography
researchProduct

Prescribing behaviour of practitioners in public and private hospitals in Pakistan evaluated using the World Health Organization (WHO) indicators: A …

2017

Summary Introduction The non-rational use of medicines by medical practitioner in their prescribing practices might lead to therapeutic failure. The aim of this research was to evaluate medical prescriptions and to highlight differences in behaviour between prescribers of public and private hospitals in Karachi (Pakistan). Materials and methods This is a retrospective study conducted between November 2015 to October 2016 in 4 public hospitals and 4 private hospitals in Karachi. A total of 120,096 (n) prescriptions were collected from both public and private hospitals. The data were evaluated with WHO indicators for rational use of medicines. Results The average number of drugs per prescript…

Polypharmacymedicine.medical_specialtybusiness.industry030503 health policy & servicesRetrospective cohort studyWorld health03 medical and health sciences0302 clinical medicineFamily medicinePublic hospitalHealth caremedicineTherapeutic failurePharmacology (medical)030212 general & internal medicineMedical prescription0305 other medical sciencebusinessAverage costLe Pharmacien Hospitalier et Clinicien
researchProduct

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

2021

From 1985 to 2016, the prevalence of underweight decreased, and that of obesity and severe obesity increased, in most regions, with significant variation in the magnitude of these changes across regions. We investigated how much change in mean body mass index (BMI) explains changes in the prevalence of underweight, obesity, and severe obesity in different regions using data from 2896 population-based studies with 187 million participants. Changes in the prevalence of underweight and total obesity, and to a lesser extent severe obesity, are largely driven by shifts in the distribution of BMI, with smaller contributions from changes in the shape of the distribution. In East and Southeast Asia…

Population -- Health aspectsLeannessBaixo peso/UnderweightnoneDouble burdenalipainoisuustulotasoglobal healthsystematic analysisSedentary behaviorsRC1200Prospective associations0302 clinical medicineunderweightnälänhätäBiology (General)skin and connective tissue diseasesChildrenComputingMilieux_MISCELLANEOUSBody mass indexHuman Nutrition & Healtheducation.field_of_studyHumane Voeding & GezondheidylipainoGeneral Medicinekansainvälinen vertailu3. Good healthWorld healthMedicineA100 Pre-clinical MedicinePopulation distributionmedicine.medical_specialtyQH301-705.5ScienceSocio-culturaleNursing.Social sciencesGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesThinnessSDG 3 - Good Health and Well-beingBMI; epidemiology; global health; none; obesity; underweightNoneHumansObesidade/ObesitySDG 2 - Zero HungereducationVLAGUS adultsOmvårdnadbody mass index; malnutrition; obesity underweightnutritional and metabolic diseasesmedicine.diseaseterveellisyysObesityFaculdade de Ciências SociaisBMI; epidemiology; global health; none; obesity; underweight; Body Mass Index; Humans; Obesity; Prevalence; Risk Factors; ThinnessGeneral BiochemistryWIASlihavuusunderweight ; obesity ; BMIBody mass indexRADemographyN.A.double burdenobesitySettore MED/09 - Medicina Internaalueelliset erotNutrition and DiseaseAnimal Nutrition[SDV]Life Sciences [q-bio]Medizin030204 cardiovascular system & hematology0601 Biochemistry and Cell BiologyChange distribution of body mass indexRisk FactorsRA0421Voeding en ZiekteEpidemiologyPrevalenceMedicine and Health SciencesGlobal healthÍndice de massa corporal/Body Mass Index030212 general & internal medicineUnderweightpainoindeksi2. Zero hungerGeneral NeuroscienceQRaliravitsemuselintarvikkeethealthPublic Health Global Health Social Medicine and EpidemiologyDiervoeding3142 Public health care science environmental and occupational health//purl.org/pe-repo/ocde/ford#3.01.03 [https]/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingChinese adultsepidemiologypooled analysisUnderweightmedicine.symptomDiet qualityB120 PhysiologyResearch Articletrends//purl.org/pe-repo/ocde/ford#1.06.03 [https]prevalencePopulationMothersGenetics and Molecular Biologybody mass indexmalnutrition3121 Internal medicineBMImedicineLife Scienceddc:6103125 Otorhinolaryngology ophthalmologyObesitykehonkoostumusNutritionAustralian adultsGeneral Immunology and Microbiology//purl.org/pe-repo/ocde/ford#3.01.04 [https]Ciências sociaisFolkhälsovetenskap global hälsa socialmedicin och epidemiologiMalnutritionEpidemiology and Global Healthsense organsEstilos de Vida e Impacto na Saúde
researchProduct

Estado actual sobre la exposición alimentaria al mercurio durante el embarazo y la infancia, y recomendaciones en salud pública

2013

La exposición a dosis altas de mercurio durante periodos vulnerables (como el embarazo y la infancia) puede tener serias consecuencias para el desarrollo cognitivo, tal como se ha constatado tras los episodios de envenenamiento agudo ocurridos en Japón e Irak. El consumo de ciertos tipos de pescado es la fuente principal de exposición a mercurio de la población general. Existe una creciente preocupación por los posibles efectos neurotóxicos del mercurio, especialmente a edades tempranas en poblaciones donde el consumo de pescado es moderado-alto. La evidencia científica hasta el momento no es concluyente. En el ámbito español, el Proyecto INMA (Infancia y Medio Ambiente) ha proporcionado in…

PopulationMercuriochemistry.chemical_element010501 environmental sciences01 natural sciencesWorld health03 medical and health sciences0302 clinical medicineSalud públicaEnvironmental healthDesarrollo cognitivomedicineFish intake030212 general & internal medicineeducationPrenatal exposure0105 earth and related environmental scienceseducation.field_of_studyPregnancybusiness.industryPublic Health Environmental and Occupational HealthFish consumptionMERCURY EXPOSUREmedicine.diseaseMercury (element)chemistryPoblación vulnerablebusiness
researchProduct